Citius Pharmaceuticals, Inc. Banner Image

Citius Pharmaceuticals, Inc.

  • Ticker CTXR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Citius Pharmaceuticals, Inc. Logo Image
  • 1-10 Employees
  • Based in Cranford, New Jersey
Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. Citius products offer new and expanded indications for previously approved pharmaceutical products as a means to achieve leading market position or market exclusivity. By using previously approved drugs withMore substantial safety and efficacy data, Citius seeks to reduce the risks associated with pharmaceutical product development. Citius is currently advancing two proprietary product candidates, their Mino-Lokā„¢ product and a Hydrocortisone-Lidocaine formulation. Citius believes the markets for its products are large and underserved by the current standard of care.
4.8 / 5.0 (92)

Citius Pharmaceuticals, Inc. reports have an aggregate usefulness score of 4.8 based on 92 reviews.

Citius Pharmaceuticals, Inc.

Most Recent Annual Report

Citius Pharmaceuticals, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Citius Pharmaceuticals, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!